Comphya Announces Publication of CaverSTIM First-in-Man Clinical Study in BJUI and ...

Peer-reviewed publications validate the scientific foundation and early clinical potential of CaverSTIM™ in restoring erectile functionLAUSANNE, Switzerland, Jan. 21, 2026 (GLOBE NEWSWIRE) -- Comphya ...
The Malaysian Reserve

Keenova Marks 100K Peyronie’s Disease Patients–a Major Milestone for an Often ...

XIAFLEX® (collagenase clostridium histolyticum) to treat their Peyronie's disease1*Diagnosis rates for the condition ...